your market intelligence analyst
Search Results
242 results
Your search is now limited to «Excipients» expert search.
Takeda Pharmaceutical 03/31/2020 11:22
Takeda Receives Positive CHMP Opinion for ADCETRIS® (brentuximab vedotin) in Combination with CHP (Cyclophosphamide, Doxorubicin and Prednisone)
More from Takeda Pharmaceutical: 03/31/2020 09:25
Condition : Pompe Disease Infantile-Onset Interventions : Biological: ATB200; Drug: AT2221 Sponsor : Amicus Therapeutics Available.
More from
Taltz should not be used in patients with a previous serious hypersensitivity, such as anaphylaxis, to ixekizumab or to any of the excipients.
More from Healthcare Sales & Marketing Network:
Business Wire 03/26/2020 16:05
DAXI combines a proprietary stabilizing peptide excipient with a highly purified botulinum toxin that does not contain human or animal-based components.
More from Business Wire:
Seeking Alpha 03/26/2020 13:30
Avantor (AVTR) is down 54% since the 2/19 market peak versus 29% for the market and 10% for closest peer TMO. It now trades at a 50%+ discount to TMO. Investors.
More from Seeking Alpha:
NutraIngredients 03/26/2020 11:40
The increasing popularity of cannabidiol (CBD) only underscores the need for accurate and informative labeling of hemp and hemp-derived CBD products, according to researchers.
More from NutraIngredients: 03/25/2020 08:48
For many specialized therapy areas, Evonik can now manufacture the customer’s API, select and supply the right functional excipient, develop the parenteral or oral formulation, and manufacture the finished drug product.
More from 03/24/2020 15:00
For small-molecule drug products, the flexible approach is used routinely for the dissolution test, which is not only dependent upon the drug substance solubility in a chosen medium, but on the excipients used in the formulation and the manufacturing process.
More from
EDQM (Europe) (EU) 03/24/2020 11:09
24 March 2020. Strasbourg, France. In January 2017, the EDQM published an update on the European Pharmacopoeia (Ph. Eur.) policy on elemental impurities in which the special case of excipients of natural origin was highlighted. At the time, and based on feedback gathered from stakeholders during workshops and conferences, the Ph. Eur. Commission decided to make an exception for these substances and keep the specific elemental impurity tests in the corresponding individual monographs.
(MENAFN - The Expresswire) Aerospace Foams Market Report 2020: Industry by Marketing Channel, Products Sales, Revenue, Price and Gross Margin. Posted o...
More from Middle East North Africa Financial Network (MENAFN):
GlobeNewswire 03/23/2020 07:00
Contraindications to Galafold include hypersensitivity to the active substance or to any of the excipients listed in the PRESCRIBING INFORMATION.
More from GlobeNewswire:
Nutritional Outlook 03/20/2020 17:40
As more states across the U.S. close businesses in the effort to control the spread of the COVID-19 pandemic, dietary industry associations are urging state governors nationwide to allow dietary supplement and natural product retailers to remain operational as essential businesses.
More from Nutritional Outlook:
Benzinga 03/19/2020 12:40
SEATTLE, March 19, 2020 (GLOBE NEWSWIRE) -- Receptor Life Sciences ("RLS"), a leading biopharmaceutical company developing FDA regulated oral and inhaled cannabinoid medicines, today announced that the United States Patent and Trademark Office has issued the Company a Patent for compositions comprising cannabinoids and the company's oral absorption enhancing excipients: U.S. Patent No. 10,588,974. Receptor's excipients increase oral cannabinoid bioavailability, reduce time to onset and can be formulated as either liquid or solid dosage forms.
More from Benzinga:
Each person recommending a prescription substitution using this product shall make such recommendations based on each such person’s professional opinion and knowledge, upon evaluating the active ingredients, excipients, inactive ingredients and chemical formulation information provided herein.
More from National Library of Medicine - DailyMed Drug Label Updates (NLM):
Healio News 03/18/2020 09:45
Welcome to another edition of CEDARS/ASPENS Debates. CEDARS/ASPENS is a joint society of cornea, cataract and refractive surgery specialists, here to discuss some of the latest hot topics in ophthalmology. The use of compounded ophthalmic medications has long been a controversial topic. While the use of these products may give patients access to medications that they would not otherwise have, whether it is due to availability or affordability, they also come with certain risks. This month, Gary Wörtz, MD, and Inder Paul Singh, MD, discuss their thoughts on the concept of using compounded.

Chemicals - Agricultural

Chemicals - Industrial

Business Issues

Companies - Public

Companies - Venture Funded

Commodity Prices

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Information Technologies

Legal and Regulatory

Political Entities


Strategic Scenarios



On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 

  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications